Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$15,830,420
+$2,240,558 QoQ
Shares Held
62,909
+0.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#717
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $186,163,406 across 16 Drug Manufacturers - General names. ABBV ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,190 | $81,789,138 | |
| 2 | JNJ |
Johnson & Johnson
|
89,403 | $22,705,679 | |
| 3 | AMGN |
Amgen Inc
|
51,552 | $18,668,010 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
62,909 | $15,830,420 | |
| 5 | MRK |
Merck & Co., Inc.
|
79,617 | $10,230,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
66,482 | $8,399,335 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
115,747 | $6,669,342 | |
| 8 | NVS |
Novartis AG
|
39,351 | $6,167,088 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,830,420 | 62,909 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $13,589,862 | 62,485 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $14,082,524 | 61,633 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $13,529,345 | 58,432 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $10,601,083 | 50,597 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,609,291 | 42,821 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $8,135,583 | 41,197 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,423,424 | 37,450 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $4,018,582 | 22,068 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,032,762 | 19,570 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,448,608 | 16,427 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,174,542 | 16,140 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,927,945 | 18,372 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,603,052 | 16,107 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,454,164 | 18,286 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,912,184 | 19,014 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,973,421 | 18,342 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $2,649,642 | 19,569 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,468,497 | 22,884 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,245,027 | 19,931 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,418,825 | 22,351 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,100,170 | 28,933 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,723,523 | 31,094 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $3,271,848 | 33,325 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,843,340 | 24,194 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||